367 related articles for article (PubMed ID: 27622507)
1. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
[TBL] [Abstract][Full Text] [Related]
2. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
[TBL] [Abstract][Full Text] [Related]
3. Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions.
Debes AK; Ali M; Azman AS; Yunus M; Sack DA
Int J Epidemiol; 2016 Dec; 45(6):2134-2139. PubMed ID: 27789673
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
[TBL] [Abstract][Full Text] [Related]
6. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
7. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
9. Assessing different measures of population-level vaccine protection using a case-control study.
Ali M; You YA; Kanungo S; Manna B; Deen JL; Lopez AL; Wierzba TF; Bhattacharya SK; Sur D; Clemens JD
Vaccine; 2015 Nov; 33(48):6878-83. PubMed ID: 26364121
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
[TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
[TBL] [Abstract][Full Text] [Related]
14. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
[TBL] [Abstract][Full Text] [Related]
15. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.
Sur D; Kanungo S; Sah B; Manna B; Ali M; Paisley AM; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Han SH; Attridge S; Donner A; Ganguly NK; Bhattacharya SK; Nair GB; Clemens JD; Lopez AL
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1289. PubMed ID: 22028938
[TBL] [Abstract][Full Text] [Related]
17. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.
Ali M; You YA; Sur D; Kanungo S; Kim DR; Deen J; Lopez AL; Wierzba TF; Bhattacharya SK; Clemens JD
Vaccine; 2016 Jan; 34(4):479-485. PubMed ID: 26707378
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial.
Fong Y; Halloran ME; Park JK; Marks F; Clemens JD; Chao DL
BMC Infect Dis; 2018 Feb; 18(1):84. PubMed ID: 29463233
[TBL] [Abstract][Full Text] [Related]
19. Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trial.
Najnin N; Leder K; Qadri F; Forbes A; Unicomb L; Winch PJ; Ram PK; Leontsini E; Nizame FA; Arman S; Begum F; Biswas SK; Clemens JD; Ali M; Cravioto A; Luby SP
Int J Epidemiol; 2017 Dec; 46(6):2056-2066. PubMed ID: 29025064
[TBL] [Abstract][Full Text] [Related]
20. Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh.
Ali M; Kim P; Zaman K; Clemens J
Int Health; 2019 May; 11(3):229-234. PubMed ID: 30496408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
